Nestlé to fully own Aimmune Therapeutics through $2bn deal

Nestlé to fully own Aimmune Therapeutics through $2bn deal

Nestlé will take full ownership of Aimmune Therapeutics, the developer of FDA approved peanut allergy drug Palforzia, by acquiring the remaining stake of 74.4% in the latter for about $2 billion. The deal is expected to help the Swiss conglomerate’s subsidiary Nestlé Health Science and Aimmune Therapeutics to create a global leader in the prevention […]

Nestlé Nespresso to expand Romont production center with $170m investment

Nestlé Nespresso to expand Romont production center with $170m investment

Nestlé Nespresso (Nespresso) will invest CHF160 million ($170.28 million) to expand its Romont production center in Switzerland to address the growing consumer demand for its premium coffees and support global development in the coming years. In this regard, the coffee company will start construction of a second production hall in June 2021 which will add […]

Nestlé increases stake in Aimmune Therapeutics after Palforzia FDA approval

Nestlé increases stake in Aimmune Therapeutics after Palforzia FDA approval

Aimmune Therapeutics, which has recently bagged approval from the US Food and Drug Administration (FDA) for its peanut allergy drug PALFORZIA (formerly AR101), has secured an additional equity investment of $200 million from Nestlé Health Science. Based in California, Aimmune Therapeutics has been focused on the development and commercialization of treatments for potentially life-threatening food […]

Allergan to sell brazikumab to AstraZeneca and Zenpep to Nestle

Allergan to sell brazikumab to AstraZeneca and Zenpep to Nestle

Allergan has agreed to sell IL-23 inhibitor brazikumab to AstraZeneca and gastrointestinal medication Zenpep (pancrelipase) to Nestle in separate agreements, as per the latest pharma acquisition news. Financial details of the two deals have not been disclosed. The divestments are being taken up in an effort to wrap up the $63 billion AbbVie acquisition of […]

Merit, Burcon, and Nestlé join forces for plant-based protein ingredients

Merit, Burcon, and Nestlé join forces for plant-based protein ingredients

Merit Functional Foods, its technology partner Burcon NutraScience, and Nestlé have signed a collaborative partnership for plant-based protein ingredients. The parties have signed a joint development agreement (JDA) in this connection with an objective to develop and commercialize the plant protein ingredients of Merit Functional Foods for use in the plant-based foods and beverages of […]

Nestlé to sell US ice cream business to Froneri for $4bn

Nestlé to sell US ice cream business to Froneri for $4bn

Nestlé has agreed to sell its US ice cream business to Froneri, its ice cream manufacturing joint venture with PAI Partners, for $4 billion, as per the latest food acquisition news. The ice cream business being divested by Nestlé in the US manufactures ice cream brands such as Häagen-Dazs, Outshine, and Drumstick. The Swiss food […]

Nestle completes $2.8bn sale of US confectionery business to Ferrero

Nestle completes $2.8bn sale of US confectionery business to Ferrero

Confectionery industry news : Nestle has completed its previously announced $2.8 billion sale of its US confectionery business to Italian chocolate manufacturer Ferrero. The Swiss food and beverage giant entered into the deal in January 2018 to sell its US confectionery business in a move to focus on its core products. Through the acquisition, Ferrero […]